Evaluation of Ozone Therapy as adjuvant therapy in cancer patients and reduction of side effects of Radiation therapy- Indian experiences [abstract]
DOI:
https://doi.org/10.7203/jo3t.3.4.2019.15540Keywords:
oncology, ozone therapy, ozone oxidative preconditioning, antioxidant defence system, oxidative stress, cellular redox balance, nitric oxide, reactive oxygen speciesAbstract
PURPOSE: India is new cancer capital of world with almost one third of cases registered from India, In this century, cancer is projected to be the leading cause of death. Neoplasia is a multifactorial process that can be broadly categorized into five etiologies: genetic, viral, chemical, physical and inflammatory. Chemical, physical and inflammatory are closely linked to reactive oxygen species (ROS), which can readily induce genomic damage. Although the precise mechanisms responsible for increased ROS stress in cancer cells have not be defined, the increase in ROS generation is attributed to active cellular metabolic activity under the influence of oncogenic signals and/or to mitochondrial malfunction in cancer cells. Ozone therapy (OT) biological effects are: cellular redox balance (OT can exert its protective effects by means of an oxidative preconditioning, stimulating and/or preserving the endogenous antioxidant systems); regulation of the immunological system, increase of prostacyclin, as well as the increase of oxygenation in tumours. Tumour Hypoxia is a well-recognized mechanism for resistance of neoplastic cells to anticancer drugs and radiation. MATERIAL and METHODS: The clinical trial included only 83 patients with mainly oral, breast and brain cancer patients in treatment with cobalt-60 therapy at Lady Ratan Tata memorial radiation department were also treated with Rectal Insufflation of an ozone-oxygen at a dose of 7mg (200 ml at 35 mcrg/ml), 6 days per week along with Minor auto haemotherapy(100 mcrg) alternatively for 6 weeks till the duration radiotherapy. RESULTS: The appearance of side effects (dermatitis, pigmentation, ulceration) minimized to 24% in the ozone group that means a significant difference post radiation. When compared to patients not treated with OT. One month after finishing the treatment, with significant difference in patients supported by OT. The clinical observation were: - Improvement in Energy Level - Feeling of Cheerfulness - Improved Appetite - Improved WBC, RBC and Hb levels - Reduction in Tumor Markers, CEA, AFP, CA125 CONCLUSION: OT is effective as adjuvant to conventional approach of Radiation in reducing side effects of radiation by improvement of blood circulation and oxygen delivery to ischemic and neoplastic tissues. Furthermore, it correct the chronic oxidative stress by upregulating the antioxidant system procuring a state of well-being in patients by activating the neuro-endocrine system.Downloads
References
Bocci V. Oxygen-Ozone Therapy. A Critical Evaluation. Dordrecht (NL): Kluwer Academic Publishers; 2002. 440 p. ISBN: 9789401599528.
Viehban-Hansler, R., Fernandez O., Fahmi Z, Ozone in Medicine: The Low Dose Concept – Guidelines and Treatment Strategies, Ozone Sci Eng. 2012;34:408-424.
Viehban-Hansler R. The Use of Ozone in Medicine, 5th edition.
Iffezheim: ODREI Pub; 2007.
Bocci V. Ozone. A new medical drug. Dordrecht (NL): Springer; 2005. 324 p. ISBN: 9789048192342.
Downloads
Published
How to Cite
-
Abstract1154
-
PDF328
Issue
Section
License
Journal of Ozone Therapy applies the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY NC 4.0) license to works we publish.
Under this license, authors retain ownership of the copyright for their content, but allow anyone to download, reuse, reprint, modify, distribute and/or copy the content as long as the original authors and source are cited. No permission is required from the authors or the publishers.
You may not use the material for commercial purposes.
Appropriate attribution can be provided by simply citing the original article, provide a link to the license, and indicate if changes were made.
You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.